EUVIMEDScopri EUVIMED
Crossref

Ginsenoside Rh1 mitigates mitochondrial dysfunction induced by myocardial ischaemia through its novel role as a sirtuin 3 activator

Shuaishuai Gong, Hong Chen, Shuhua Fang, Mengyu Li, Jingui Hu, Yue Li, Boyang Yu, Junping Kou iD, Fang Li iD

British Journal of Pharmacology · 2025-07 · 182 (13) · 3017-3035

DOI: 10.1111/bph.70022 ↗

At a glance

Journal article in British Journal of Pharmacology, published online on 2025-03-28. Written by Shuaishuai Gong and 8 co-authors. Institution: Jiangsu Key Laboratory of TCM Evaluation and Translational Research, Research Center for Traceability and Standardization of TCMs, School of Traditio…. Major MEDLINE topics: Ginsenosides, Sirtuin 3, Myocardial Ischemia, Mitochondria. Cited 29 times so far (Crossref); 50 references. Funded by: National Natural Science Foundation of China, State Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources, Fundamental Research Funds for the Central Universities.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Background and Purpose The sirtuin 3 (SIRT3) signalling pathway is an essential target for various cardiovascular diseases (CVDs), although effective interventions in myocardial ischaemia‐induced mitochondrial dysfunction remain to be elucidated. Here, we discovered a potent SIRT3 activator and explored its efficacy and mechanism against mitochondrial dysfunction. Experimental Approach Molecular docking screened for SIRT3 activators among the 10 more common rare ginsenosides. In vivo, left coronary artery ligation induced myocardial ischaemia injury, followed by echocardiography, histopathology and serum biochemical indicators, in C57BL/6J mice. Expression levels of mitophagy and mitochondrial dynamics‐associated proteins were examined by western blot (WB), immunofluorescence (IF) and immunohistochemistry (IHC). In vitro, oxygen–glucose deprivation‐induced hypoxic injury in neonatal rat ventricular myocytes, and cell viability and mitochondrial function were investigated. SIRT3 small interference RNA (siRNA) was transfected into cardiomyocytes to validate mitochondrial dynamics and mitophagy mechanism regulated by ginsenoside Rh1. Key Results Rh1 exhibited the strongest binding affinity as an effective activator of SIRT3. Rh1 improved cardiac function and mitigated myocardial ischaemia injury in vivo. Rh1 ameliorated oxidative stress, improved mitochondrial network morphology and mitochondrial respiration function in hypoxia‐injured cardiomyocytes. Rh1 bound to SIRT3 and simultaneously up‐regulated Foxo3a, facilitating its nuclear translocation and reducing acetylation of Foxo3a. Rh1 markedly promoted mitochondrial fusion, inhibited mitochondrial fission and accelerated mitophagy. SIRT3 siRNA abrogated the regulation of Rh1 on oxidative stress, mitochondrial dynamics and mitophagy. Conclusion and Implications Rh1 is a novel SIRT3 activator and protects against myocardial ischaemia‐induced mitochondrial dysfunction, providing new clues to prevent and treat ischaemic injury‐associated CVD.

Subjects

MeSH terms (MEDLINE)

GinsenosidesSirtuin 3Myocardial IschemiaMitochondriaAnimalsMice, Inbred C57BLMaleRatsMiceMyocytes, CardiacRats, Sprague-DawleyCells, CulturedMolecular Docking SimulationSirtuins

Author keywords

SIRT3ginsenoside Rh1mitochondrial dynamicsmitochondrial dysfunctionmitophagymyocardial ischaemia

Substances

GinsenosidesSirtuin 3Sirt3 protein, mouseSIRT3 protein, ratSirtuins

Authors and institutions

  • Jiangsu Key Laboratory of TCM Evaluation and Translational Research, Research Center for Traceability and Standardization of TCMs, School of Traditional Chinese Pharmacy, Affiliated Jiangning Hospital of Chinese Medicin…
  • Department of Pharmacy, Nanjing Lishui People's Hospital, Zhongda Hospital Lishui Branch Southeast University, Nanjing, China.
  • Nanjing Jiangning Hospital of Chinese Medicine, Nanjing, China.

ORCID profiles: Junping Kou, Fang Li

Funding

  • National Natural Science Foundation of China
  • State Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources
  • Fundamental Research Funds for the Central Universities
  • Young Talent Support Project of Jiangsu Association for Science and Technology
  • Qinglan Project of Jiangsu Province of China
  • Research Project Funding from Affiliated Jiangning Hospital of Chinese Medicine

Cite

APA

Gong, S., Chen, H., Fang, S., Li, M., Hu, J., Li, Y., Yu, B., Kou, J., & Li, F. (2025). Ginsenoside Rh1 mitigates mitochondrial dysfunction induced by myocardial ischaemia through its novel role as a sirtuin 3 activator. British Journal of Pharmacology, 182(13), 3017-3035. https://doi.org/10.1111/bph.70022

Vancouver

Gong S, Chen H, Fang S, Li M, Hu J, Li Y, et al. Ginsenoside Rh1 mitigates mitochondrial dysfunction induced by myocardial ischaemia through its novel role as a sirtuin 3 activator. British Journal of Pharmacology. 2025;182(13):3017-3035. doi:10.1111/bph.70022

BibTeX
@article{Gong2025,
  author = {Gong, Shuaishuai and Chen, Hong and Fang, Shuhua and Li, Mengyu and Hu, Jingui and Li, Yue and Yu, Boyang and Kou, Junping and Li, Fang},
  title = {Ginsenoside Rh1 mitigates mitochondrial dysfunction induced by myocardial ischaemia through its novel role as a sirtuin 3 activator},
  journal = {British Journal of Pharmacology},
  year = {2025},
  volume = {182},
  number = {13},
  pages = {3017--3035},
  doi = {10.1111/bph.70022}
}
Start for free →